INBXV stock
INBXV · Inhibrx Inc. Ex-distribution When-Issued · NASDAQ
What is the latest news on INBXV stock?
SECago
SEC Form 15-12G filed by Inhibrx Inc. Ex-distribution When-Issued
15-12G - Inhibrx, Inc. (0001739614) (Filer)
All INBXV newsLatest news
3 items- SECSEC Form 15-12G filed by Inhibrx Inc. Ex-distribution When-Issued15-12G - Inhibrx, Inc. (0001739614) (Filer)
- 13D/GSEC Form SC 13G/A filed by Inhibrx Inc. Ex-distribution When-Issued (Amendment)SC 13G/A - Inhibrx, Inc. (0001739614) (Subject)
- INSIDERViking Global Investors Lp disposed of $214,524,780 worth of shares (7,150,826 units at $30.00) (SEC Form 4)4 - Inhibrx, Inc. (0001739614) (Issuer)
Inhibrx Inc. Ex-distribution When-Issued (INBXV) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for INBXV in the last 30 days. The most recent was published Jun 10, 2024.
INBXV FAQ
4 questionsWhere does INBXV stock trade?
Inhibrx Inc. Ex-distribution When-Issued (INBXV) is listed on NASDAQ.What sector and industry is INBXV in?
Inhibrx Inc. Ex-distribution When-Issued operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.What companies are similar to INBXV?
Notable peers in the same industry include EXEL (Exelixis Inc.), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.). Compare INBXV side-by-side with any of them on Quantisnow.How can I track INBXV on Quantisnow?
Quantisnow aggregates Inhibrx Inc. Ex-distribution When-Issued's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow INBXV to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change